INTRODUCTION
Nitric oxide, a highly bioactive but potentially toxic molecule, is synthesized in multiple cell types by a set of specific enzymes, nitric oxide synthases (NOSs), that act in response to a wide array of stimuli [1] . Nitric oxide is thought to be involved in several physiological functions [2] , as well as to be implicated in the onset and maintenance of certain pathological conditions [3] . The beneficial effects of this compound, and its toxicity, are due to its reactivity towards a variety of molecular targets. Chemistry of nitric oxide involves, in fact, various redox forms that include NO (commonly designated nitric oxide, but most properly identified as nitrogen monoxide), NOd (nitric oxide), NO + and NO − (nitrosonium and nitroxyl anion, respectively), and the related oxides, anhydrides and acids [4, 5] . The high reactivity and potency of these molecules induce the existence in the cells of control mechanisms overseeing excessive synthesis of their common precursor, NO. Indeed, in the case of the ' constitutive ' NOS isoforms, which require calcium as their main activator, the intracellular concentration of free calcium ions undergoes rapid fluctuations, allowing readily reversible enzyme activation. In contrast, fine regulation of NO production by the ' inducible ' NOS (iNOS), characterized by stimulus-independent catalytic activity, is rather different. Inducers and modulators, in fact, determine fluctuations of its activity in the cell by affecting expression of the iNOS gene [6] . As a consequence, induction of enzyme activity is less readily reversible in this case when compared with that involving constitutive NOS isoforms, since the main controls for NO production reside here on transAbbreviations used : AMV, avian myeloblastosis virus ; AP-1, activator protein-1 ; CAT, chloramphenicol acetyltransferase ; DMEM, Dulbecco's modified Eagle's medium ; dNTP, deoxyribonucleotide triphosphate ; IFN-γ, interferon γ ; IL-1β, interleukin-1β ; iNOS, inducible nitric oxide synthase ; IRF, IFN regulatory factor ; ISREs/IREs, IFN-stimulated response elements/IFN response elements ; L-NMMA, N G -monomethyl-L-arginine ; LPS, lipopolysaccharide ; NF-IL6, nuclear factor interleukin 6 ; NF-κB, nuclear factor κB ; NO, nitric oxide ; NOS, NO synthase ; Oct, octamer factors ; ssDNA, singlestranded DNA ; SV40, simian virus 40 ; TBE, Tris-borate EDTA buffer ; TNF-α, tumour necrosis factor-α.
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k775 and the other between k420 and k47, with respect to the major transcriptional start site of the iNOS gene. The upstreammost region also mediates promoter trans-activation by IFN-γ.
As reported earlier for transcription of the endogenous iNOS gene, combined stimulation of RAW 264.7 cells with IFN-γ and LPS results in lower activation of the transfected promoter, when compared with LPS alone. N G -Monomethyl--arginine, a competitive inhibitor of nitric oxide synthase activity, enhances iNOS gene mRNA induction and promoter activation by IFN-γ and LPS, indicating that nitric oxide can influence negatively the responsiveness of this gene to inducers. These results suggest the possibility of a negative regulatory feedback exerted by iNOS on the transcriptional activation of its own gene.
criptional regulation of this gene. The pathways regulating NO production by iNOS are thus likely to be endowed with feedback controls acting on transcription of this gene that avoid NO, and its redox derivatives, reaching toxic concentrations in the cell. One of the best-characterized responses of the murine iNOS gene occurs during activation of macrophages by interferon γ (IFN-γ) or bacterial lipopolysaccharide (LPS). In this case, exposure of quiescent cells to the inducer is followed by transcriptional activation of this gene, with subsequent accumulation of the corresponding mRNA and active enzyme [1] . Transcription requires on-going protein synthesis, indicating that it is a delayed cellular response to the stimulus mediated, at least in part, by the products of ' primary-response ' genes [7, 8] . While both IFN-γ or LPS are effective on their own, they do not seem to co-operate efficiently with each other on enhancement of iNOS gene transcription, since full stimulation of the cells with both inducers is not followed by higher transcriptional activity of this gene [7] . Some authors reported, however, that IFN-γ is not always effective on its own, requiring LPS to achieve full transcriptional stimulation [9, 10] , implying that the two inducers can, in certain circumstances, co-operate in inducing iNOS gene expression.
The basic mechanisms for transcriptional regulation of the iNOS gene are currently being actively investigated, and certain cis-regulatory elements involved in this regulation have been identified [11] . For example, gene ' knock-out ' experiments involving interferon regulatory factor 1 (IRF-1) and nuclear factor interleukin 6 (NF-IL6), as well as IFN-γ, are consistent with the previous assumption that IRF-1, in conjunction with IFN-γ, is critical for transcriptional regulation of the iNOS gene, whereas NF-IL6 does not seem to be essential [12] [13] [14] . There are, however, still many aspects of the regulation of this gene in different cells and under different conditions that remain to be solved. In particular, it is clear that transcriptional activation of the iNOS gene results from the balanced effects of both positively and negatively acting factors, which combine under different conditions to yield various degrees of gene activation.
Because NO is a potentially toxic agent, much attention has been paid to understanding its cytotoxic effects, especially in immune responses. The ever increasing amount of information on the effects of NO on gene expression, however, clearly indicates that NO may be an important mediator of gene regulation [15] . A quite interesting model for NO action through cellular iron has been proposed recently [16] , in addition to its well-accepted action through cyclic GMP. In this respect, possible effects of NO on iNOS gene expression have been reported [17, 18] . These experiments suggest that NO can be a regulator of the iNOS gene, although defined mechanism(s) remain to be determined.
To further our understanding of the mechanisms that control iNOS activity, we have cloned the mouse iNOS gene promoter and analysed its response to both IFN-γ and LPS by transfecting it in mouse macrophage-like RAW 264.7 cells [7] . In this study we performed a genetic analysis of the regulatory regions endowed in its 5h-flanking DNA. This allowed the identification of two main regulatory regions : one, centred around the transcriptional start site of the gene, that includes cis-acting element(s) responsive to LPS, and the second, located far upstream, endowed with element(s) responsive to both IFN-γ and LPS. Furthermore, by using a competitive inhibitor of NOS, we could identify in the activity of iNOS itself a factor negatively affecting transcription of this gene.
MATERIALS AND METHODS

Reagents and cell culture
The mouse macrophage-like cell line RAW 264.7 (A.T.C.C. TIB71) was obtained from the American Type Culture Collection (U.S.A.). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM ; Gibco, U.S.A.), supplemented with 2 mM -glutamine, antibiotics (50 units\ml penicillin-G, 50 mg\ml streptomycin and 125 ng\ml amphotericin B ; Sigma, U.S.A.) and 10 % (v\v) fetal bovine serum (MultiSer ; Cytosystems, Australia). Bacterial LPS (from E. coli serotype 0127 : B8) was from Sigma, recombinant mouse IFN-γ was a generous gift of Shionogi Pharmaceuticals Company (Japan). RNase ONE, RNasin ribonuclease inhibitor, T3 and T7 RNA polymerases, ribonucleotides, deoxyribonucleotide triphosphates (dNTPs), RQ1 DNase and T4 polynucleotide kinase were from Promega 
Mapping of the transcriptional start site by RNase protection
RNase protection experiments were carried out using labelled antisense and sense (negative control) RNA probes synthesized according to standard procedures [19] .
The DNA fragments containing the presumptive 5h-end of the iNOS gene were subcloned from the λ clones to the SmaI or XbaI sites of the phagemid Bluescript II SKj. After digestion with the appropriate restriction endonucleases (AccI, HincII or SacI), RNA probes (riboprobes) were synthesized and treated with RQ1 DNase to remove the plasmid template according to standard protocols [19] . Following phenol\chloroform extraction, the labelled probes were purified by electrophoresis on 5 % polyacrylamide\7 M urea gels, followed by elution from the matrix in 2 M ammonium acetate, 1 % SDS and 25 mg\ml tRNA, at 37 mC for 4 h. Purified riboprobes were recovered by ethanol precipitation and dissolved in hybridization buffer (80 % formamide, 40 mM Pipes, pH 6.4, 0.4 M sodium acetate, 1 mM EDTA). Total RNA (10 µg), purified from RAW 264.7 cells as described previously [7] , was precipitated and carefully redissolved in 30 µl of hybridization buffer containing 1.5i10& c.p.m. labelled RNA probe. Samples were then heated to 85 mC for 10 min, followed by hybridization at 45 mC for 12-16 h. Nonhybridized riboprobe and excess cellular RNA were removed by RNase ONE digestion (in 300 µl of 10 mM Tris\HCl, pH 7.5, 5 mM EDTA, 200 mM sodium acetate containing 0.1 unit of RNase ONE) according to standard protocols [19] . Following inactivation of the ribonuclease by addition of 0.1 % SDS, 10 µg of tRNA was added as carrier to each sample, and the RNaseresistant fragments were concentrated by ethanol precipitation in 4 ml of 80% formamide\10 mM EDTA\0.1 % Bromophenol Blue\0.1 % xylene cyanol\0.1 % SDS and resolved on an 8 % polyacrylamide\7 M urea sequencing gel. The labelled products were detected by autoradiography at k90 mC using Kodak XAR-5 films.
Molecular-mass markers were labelled with DNA fragments obtained in a sequencing reaction carried out using a singlestranded DNA (ssDNA) template of known sequence. Sizes of RNA fragments were calculated considering the differences in electrophoretic mobility between ssDNA and RNA [19] .
Determination of iNOS mRNA capsite by primer extension
Three different antisense oligonucleotide primers, derived from the known sequence of the murine iNOS cDNA [20] , were used : m0 (5h-AAC CAG TGA CAC TGT GTC CCG TGG ; from position 29 to position 6 of the cDNA : shown in Figure 1 ), m1 (5h-ACA GCT CAG TCC CTT CAC CAA ; from position 68 to position 48 of the cDNA), and m2b (5h-GTG AAC AAG ACC CAA GCG TGA GG ; from position 110 to position 88 of the cDNA). Primers were 5h-end-labelled with [γ-$#P]ATP using polynucleotide kinase and then purified by electrophoresis on 15 % polyacrylamide gels in TBE buffer (Tris-borate EDTA buffer), according to standard protocols [19] . Labelled oligonucleotide (1i10& c.p.m.) was hybridized to 10 µg of total RAW 264.7 cells RNA in 15 ml of hybridization buffer (150 mM KCl, 10 mM Tris, pH 8.3, 1 mM EDTA) for 90 min at 65 mC, followed by slow cooling of the samples to room temperature. Primer was then elongated at 42 mC for 1 h using 20 units of AMV reverse transcriptase in 45 µl of 20 mM Tris, pH 8.3, containing 10 mM MgCl # , 6 mM -dithiothreitol, 0.6 mM dNTP and 150 µg\ml actinomycin D. Sonicated DNA (70 µg\ml) was then added to each sample and RNA was removed by digestion with RNase A (14 µg\ml) for 15 min at 37 mC. The samples were extracted once with phenol\chloroform and concentrated by ethanol precipitation in 5 ml of 80 % formamide\10 mM EDTA\0.1 % Bromophenol Blue\0.1 % xylene cyanol\0.1 % SDS and resolved on an 8 % polyacrylamide\7 M urea sequencing gel.
The same primers were used also for sequencing genomic DNA clones collinear with the 5h-end of the cDNA. In each case, the sequencing reactions were run side by side with the corresponding samples and used as molecular markers to determine the exact size of each reverse transcription product. Regulation of iNOS gene transcription
Construction of iNOS-CAT reporter recombinants
Cloning of the mouse iNOS gene promoter region and construction of the reporter gene piNOS CAT1 has been described previously [7] . All deletion mutants of piNOS CAT1 were constructed by restriction enzyme digestion and re-ligation, according to standard protocols [19] .
Transient transfection and chloramphenicol acetyltransferase (CAT) assays
For transient transfections, RAW 264.7 cells were plated on Day 1 at about 10-20 % confluency in DMEM\10 % (v\v) fetal calf serum culture medium. On Day 2, fresh medium was added and cells were transfected, using the calcium phosphate-DNA coprecipitation method [21] CAT enzyme assays were performed on whole-cell extracts as described previously [22] , after normalization for β-galactosidase activity and under assay conditions where substrate conversion was within a linear range with respect to the concentration of cell extract used. CAT activity was calculated as c.p.m. of acetylated chloramphenicol formed\h per unit of β-galactosidase.
Northern-blot analysis
Cells were seeded on 150-mm-diam. dishes as described above and 24 h later were treated with 5 µg\ml LPS or 10# units\ml IFN-γ, in the absence or presence of 1 mM N G -monomethyl--arginine (L-NMMA), for an additional 24 h. Total cellular RNA was then extracted with 4 M guanidinium isothiocyanate and iNOS and β-actin mRNAs were detected by Northern-blot hybridization, after 1 % agarose gel electrophoresis, as described previously [7, 8] .
RESULTS AND DISCUSSION
Isolation of genomic clones including the 5h-end of the mouse iNOS gene has been described previously [7] . A detailed characterization of the promoter region of this gene was carried out by both ' RNAse mapping ' and ' primer extension ', and the results are summarized in 
Figure 2 Identification of IFN-γ-and LPS-responsive regions in the 5h-flanking region of the mouse iNOS gene promoter
Top : Schematic representation of the genomic organization of the mouse iNOS gene promoter region and 5h-flanking DNA and of the iNOS-CAT reporter plasmids used. Bottom : Effects of IFN-γ and LPS on expression of the iNOS-CAT reporters in RAW 264.7 cells. The iNOS-CAT DNAs (5 µg of piNOS CAT1 and an equivalent molar amount of each of the deletion mutants) were transfected in semi-confluent cultures by the calcium phosphate-DNA co-precipitation method. CAT activity was measured in whole-cell extracts from cells treated without (k) or with (j) the indicated inducer for 24 h before harvesting. The data reported are representative of multiple, independent transfection experiments, corrected for changes in transfection efficiency as described in the Materials and methods section.
3, 4 and 5, respectively). In all cases, the 5h-end of the mRNA is identical and corresponds essentially to that described previously both in subclones of RAW 264.7 cells unresponsive to IFN-γ alone [9, 10] and in primary mouse macrophages [9] . RNase mapping results were confirmed by primer extension analysis of iNOS mRNA in RAW 264.7 cells ( Figure 1B, lane 4) .
A 5 kb BglII-BglII fragment, including about 4 kb of 5h-flanking DNA, the first non-coding exon and 340 bp of the first intron of the iNOS gene, was subcloned upstream of the CAT coding sequence in pBLCAT5, to constitute the reporter piNOS CAT1. We have shown previously that this recombinant gene is expressed upon transient transfection in RAW 264.7 cells and it is inducible by either IFN-γ or LPS [7, 8] . The transfected iNOS gene promoter was found to be active in different mouse as well as human cell lines, including Balb\3T3 fibroblasts, Hep G2 hepatoma cells, MCF-7 breast cancer cells, U 251 MG and A-172 glioblastoma cells, confirming the notion that this gene is expressed in tissues of different embryonal origin (results not shown). Moreover, transcription of this reporter could be activated by IFN-γ and LPS in RAW 264.7 and Balb\3T3 cells (about 10-15-fold and 2-3-fold respectively), but not by LPS in all other cell types investigated here (results not shown). Since these cell lines are responsive to various different inducers, they will be useful to identify within the iNOS gene promoter the elements responsive to multiple signal transduction pathways. Indeed, in A-172 cells, piNOS CAT1 was found to be responsive to a combined stimulation of the cells with IFN-γ, tumour necrosis factor α (TNF-α) and interleukin 1β (IL-1β) [23] .
A series of deletion mutants of piNOS CAT1 were then constructed and tested for their responses to IFN-γ and LPS in RAW 264.7 cells. The results, normalized for variations in transfection efficiency by using β-galactosidase as an internal control, are reported in Figure 2 (as actual autoradiograms of the TLC plates from representative transfection experiments) and in Table 1 (as the average results obtained in multiple, independent transfection experiments by quantifying CAT activity in cell extracts). piNOS CAT1, 2, 3 and 4 were all equally expressed and responsive to either LPS or IFN-γ stimulation, indicating that elements within the first 1541 bp upstream of the iNOS gene are sufficient to confer both basal activity and inducibility to this promoter. As reported previously [7] , while each inducer alone was efficient in enhancing transcription of these reporters, costimulation of the cells with IFN-γ and LPS was not followed by a synergistic effect on the promoter (compare, for example, lanes 2 and 3 with lane 4, or lanes 14 and 15 with lane 16, and see the corresponding data in Table 1 ). The possible significance of these data is discussed below. Deletion of iNOS DNA comprised between the SphI (k1541) and either the AccI (k775) or the XbaI (k420) restriction sites, as in piNOS CAT5 and 6, is followed by a complete loss of the response to IFN-γ, while that to LPS, although strongly reduced, is still detectable (Figure 2 , compare lane 17 with lanes 18 and 19, or lane 21 with lanes 22 and 23). The residual responsiveness to LPS is lost when deletion is extended to the PstI site located at k47, as in piNOS CAT7 (Figure 2, lanes 29 to 32) . These results indicate that cis-acting elements mediating stimulation of the iNOS gene promoter by LPS in RAW 264.7 macrophages are multiple and included within two separate DNA regions, located at a distance from each other : one between positions k1541 and k775 and the other between positions k420 and k47. In contrast, the element(s) mediating the IFN-γ response are confined in the upstream-most region, since cloning of this DNA upstream of the iNOS gene promoter, as in piNOS CAT47, restores the ability of IFN-γ to activate the reporter gene (compare lane 25 with lane 26 in Figure 2 and see Table 1 ).
Both of these DNA regions comprise multiple sequences homologous to genetic elements known to mediate the genomic effects of either of these inducers, including activator protein 1 (AP-1), nuclear factor κB (NF-kB), NF-IL6 and octamer factor (Oct) sites, IFN-stimulated response elements\IFN response elements (ISREs\IREs) and γ-activated factor binding sequences (GASs) ( [9, 10] and our results not shown), that in most cases are fairly well conserved, in structure and localization, in the human
Table 1 Identification of IFN-γ-and bacterial LPS-responsive regions upstream of the mouse iNOS gene
The data represent the average (pS.D.) of results obtained in multiple (n) transfection experiments, performed in RAW 264.7 cells as described in the text. iNOS gene promoter also [24] . There are several lines of evidence indicating that some of these elements mediate, at least in part, the effects of LPS and IFN-γ on transcription of the iNOS gene. Kamijio et al. [12] , using IRF-1-deficient mice, demonstrated that this transcription factor is essential for induction of NOS by IFN-γ in macrophages. Two adjacent IREs (IRF-response elements) are located within the upstream DNA region shown here to mediate IFN-γ activation. In addition, since the IRF-1 gene is generally induced by treatment with IFNs, as well as TNF-α and IL-1 [25] , the known requirement for de no o protein synthesis in induction of the iNOS gene by cytokines [7] could well be explained by the need for neosynthesis of such a transcription enhancer factor. It is worth mentioning here that the iNOS gene is not always readily responsive to IFN-γ in macrophages, since several reports indicate that co-stimulation of the cells with LPS is often required to achieve detectable activation of this gene by the lymphokine [9, 10] . IRF-1, and possibly other factors synthesized in response to IFN, could in certain conditions require post-translational modifications, mediated by the signal transduction pathways activated by LPS, to be fully active. Alternatively, since both IRF-1 and IRF-2 genes are responsive to the NF-κB transcription factor [25] , known to be activated by LPS in macrophages [26] , activation of an LPS-responsive pathway leading to NF-κB could be required to boost IRF expression when this is too low to unchain the IFN-γ effects. At the same time, IFN-responsive and LPS-responsive factors could co-operate with each other in stimulating transcription of the iNOS gene : an NF-κB site, for example, is located in close proximity to the two IRF-1 sites within the k1541 to k775 region of the gene, so that DNA-bound factors could functionally interact with each other in this case. Concerning the elements responsive to LPS, multiple putative target sequences, in particular potential AP-1, octamer proteins, NF-IL6 and NF-κB binding sites, are located in both responsive regions. An NF-κB-like element is located in each of the two LPS-responsive regions identified here, the first at position k970 and the other at k80. It is possible that these two sites cooperate with each other, and possibly with other cis-acting elements, in achieving full stimulation of the iNOS gene promoter by LPS (Table 1) . In fact, NF-κB mediates multiple effects of LPS on transcription in macrophages, and low concentrations of cycloheximide, a condition known to induce NF-κB activity [19] , have been shown to super-induce iNOS mRNA and to stimulate transcription of piNOS CAT1 in RAW 264.7 cells [7, 8] . More convincingly, Xie et al. [11] showed recently that the NF-κB site located at about position k80 is critical in the stimulation of iNOS transcription by LPS in RAW 264.7 cells and that pyrrolidine dithiocarbamate, an antioxidant that acts as an inhibitor of NF-κB activation, can block NO production by LPS-treated RAW 264.7 cells. Recently, mice lacking the NF-IL6 gene were described by Tanaka et al. [14] in which the iNOS gene is fully induced by LPS. This suggests that the putative NF-IL6 site is not strictly required for full iNOS induction in this case. Alternatively, however, this sequence could mediate the action of NF-IL6-like factors that are responsive to LPS stimulation.
Analysis of iNOS gene transcription in IFN-γ-and LPSstimulated RAW 264.7 cells shows that while the two inducers are active on their own they do not seem to co-operate efficiently with each other in achieving a synergistic effect on transcription of the iNOS gene [7] . They do co-operate, however, at the posttranscriptional level, so that the final result is a relatively modest co-operation between the two stimuli in inducing NO production by these macrophages [7] . Interestingly, this is also true for the cloned gene promoter, when this is re-introduced in RAW 264.7 cells ( Table 1) . Comparison of the response of piNOS CAT1-4 to IFN-γ, LPS or both inducers combined shows how this is, paradoxically, bipartite : strong when the cells are stimulated with only one inducer and moderate when the two stimuli are combined (Table 1) . This is apparently independent of the nature of the DNA elements involved, since it occurs also when the reporter gene includes only the promoter-near region, responsive only to LPS (compare, in Table 1 , expression of piNOS CAT5 or 6 in cells treated with LPS versus cells exposed to IFNγjLPS). It seems that the signal transduction pathways involved, i.e. IFN-responsive and LPS-responsive, and\or their effectors, in this case are not fully efficient when activated together. Alternatively, the two stimuli combined could induce in the macrophage a condition that prevents excessive activation of the iNOS gene, that would in turn result in overproduction of NO with possible toxic effects for the cell. NO itself is a possible candidate for a central role in regulation of its synthesis via iNOS, since certain effects of this molecule, and its redox derivatives, on gene transcription have been documented [27] . Furthermore, an increase of NO concentration is bound to modify the oxidoreductive potential within the cell, as a consequence of its high reactivity [4] . The activity of certain transcription factors, including NF-κB [28] , is influenced by changes in the redox balance within the cells. To test this last possibility, i.e. if NO can affect expression of the iNOS gene, we have used L-NMMA, a competitive inhibitor of NO synthases, to prevent NO production by iNOS synthesized in RAW 264.7 cells in response to IFN-γ and LPS. L-NMMA (1 mM) was added to the culture medium prior to exposure of the cells to either IFN-γ, LPS or both inducers combined. As shown in Figure 3 , L-NMMA can stimulate significantly iNOS mRNA accumulation in cells treated either with LPS or with IFN-γ (2-to 3-fold increase on average, compared with that achieved by each inducer alone). The effects of the inhibitor were also tested on the cloned iNOS promoter. The results, reported in Figure 4 and in Table 1 , show clearly that inhibition of NO synthesis in macrophages with L-NMMA potentiates iNOS gene promoter activation by IFN-γ and LPS, and more so when both inducers are used in combination. The permissive effects of the inhibitor are more evident on piNOS CAT1, 2 or 4 reporters, which include both the regulatory regions described above (compare lane 4 with lane 8 and lane 12 with lane 16 in Figure 4 and see the data relative to piNOS CAT 1, 2 and 4 expression in Table 1 ). No changes in expression of pSV2-CAT or pRSV-CAT, two constitutive CAT reporters based on the SV40 early promoter and the Rous sarcoma virus long terminal repeat (LTR), could be detected in the presence either of the inducers or of the inhibitor (results not shown), suggesting that L-NMMA does not have a generalized effect on transcription or CAT enzyme activity itself, but instead that its action is likely to be specific for the iNOS gene, mediated by inhibition of NO synthase activity. PTIO (4,4,5,5,-tetramethyl-2-phenyl-imidazoline-1-oxyl 3-oxide), an 
macrophages
Aliquots (5 µg) of piNOS CAT1 or 2 DNA were transfected by the calcium phosphate-DNA coprecipitation method. The transfected cells were then incubated for 24 h in medium alone, or in medium supplemented with IFN-γ and/or LPS, in the presence or absence of 1 mM L-NMMA as indicated. CAT activity was measured in whole-cell extracts, corrected for differences in transfection efficiency by normalizing the amount of extract used in each case to its content in β-galactosidase internal control, as described in the Materials and methods section. The data reported are representative of two, independent transfection experiments.
imidazolinoxyl N-oxide that traps NO released from the cells [29] , did not have any effect on transcription of the iNOS-CAT reporters, either in the presence or absence of IFN-γ and LPS (results not shown), suggesting that the putative activity of NO and\or its derivatives on the iNOS gene promoter is very rapid and occurs predominantly through an intracellular mechanism.
In preliminary experiments, overexpression of NOS in RAW 264.7 cells by transfection of an expression vector encoding the rat iNOS cDNA results in a dramatic reduction of the piNOS CAT1 response to either IFN-γ or LPS, which is relieved by pretreatment of the cells with L-NMMA (A. Weisz, H. Adachi and H. Esumi, unpublished work). Preliminary results show that sodium nitroprusside, an NO-generating compound, did not show an inhibitory effect on the iNOS reporter genes in these cells (results not shown), suggesting that only certain redox derivatives of NO could be involved in this putative autoregulatory loop. Further studies, now in progress, are required to clarify the full role of NO and its derivatives on the fine tuning of iNOS gene transcriptional activation by cytokines and other inducers. The possibility that NO derivatives influence negatively gene expression in NOS-expressing cells, and possibly also in NO target cells, reveals for the first time wholly new possible scenarios that, with the identification of the target molecules mediating these effects, are likely to expand our knowledge on the full range of biological activities of these molecules.
